CY 2017 OPPS/ASC FINAL RULE			
"Addendum O:  New Category I and III CPT Codes Effective January 1, 2017"			
CPT codes and descriptions only are copyright 2016 American Medical Association.  All Rights Reserved.  Applicable FARS/DFARS Apply. 			
"NOTE 1:  As discussed in sections III.A. (Proposed OPPS Treatment of New CPT and Level II HCPCS) and XII.B. (Proposed Treatment of New Codes) of the CY 2017 OPPS/ASC proposed rule, we requested comments on the new CPT codes below.  Specifically, we requested comments on the OPPS status indicator and APC assignments, as well as the ASC payment indicator assignments.  Listed below in column A are the final CY 2017 5-digit CPT codes.  The final CY 2017 payment rates for these codes can be found in OPPS Addendum B, ASC Addendum AA, and ASC Addendum BB of the CY 2017 OPPS/ASC final rule, which are available via the Internet on the CMS Web site."			
"NOTE 2:  Comments were not accepted for the new Category I CPT  laboratory codes that were not assigned to ""NP"" comment indicator in the CY 2017 OPPS/ASC proposed rule.  Comments to these codes should have been submitted at the Clinical Laboratory Fee Schedule (CLFS) Public Meeting, which was held on July 18, 2016."			
CY 2017 OPPS/ASC                                                                          FINAL RULE                                                                                  5-Digit  CPT Code	CY 2017 OPPS/ASC                                                                                                                              Proposed Rule                                                                    5-Digit  Placeholder Code	Long Descriptor	CY 2017 OPPS/ASC                                                                                             Proposed Rule                                                  Comment Indicator (CI)
22853	22X81	"Insertion of interbody biomechanical device(s) (eg, synthetic cage, mesh) with integral anterior instrumentation for device anchoring (eg, screws, flanges), when performed, to intervertebral disc space in conjunction with interbody arthrodesis, each interspace (List separately in addition to code for primary procedure)"	NP
22854	22X82	"Insertion of intervertebral biomechanical device(s) (eg, synthetic cage, mesh) with integral anterior instrumentation for device anchoring (eg, screws, flanges), when performed, to vertebral corpectomy(ies) (vertebral body resection, partial or complete) defect, in conjunction with interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure)"	NP
22859	22X83	"Insertion of intervertebral biomechanical device(s) (eg, synthetic cage, mesh, methylmethacrylate) to intervertebral disc space or vertebral body defect without interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure)"	NP
22867	228X1	"Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; single level"	NP
22868	228X2	"Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; second level (List separately in addition to code for primary procedure)"	NP
22869	228X4	"Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; single level"	NP
22870	228X5	"Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; second level (List separately in addition to code for primary procedure)"	NP
27197	271X1	"Closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral; without manipulation"	NP
27198	271X2	"Closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral; with manipulation, requiring more than local anesthesia (ie, general anesthesia, moderate sedation, spinal/epidural)"	NP
28291	282X1	"Hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint; with implant"	NP
28295	282X2	"Correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with proximal metatarsal osteotomy, any method"	NP
31572	317X1	"Laryngoscopy, flexible; with ablation or destruction of lesion(s) with laser, unilateral"	NP
31573	317X2	"Laryngoscopy, flexible; with therapeutic injection(s) (eg, chemodenervation agent or corticosteroid, injected percutaneous, transoral, or via endoscope channel), unilateral"	NP
31574	317X3	"Laryngoscopy, flexible; with injection(s) for augmentation (eg, percutaneous, transoral), unilateral"	NP
31551	315X1	"Laryngoplasty; for laryngeal stenosis, with graft, without indwelling stent placement, younger than 12 years of age"	NP
31552	315X2	"Laryngoplasty; for laryngeal stenosis, with graft, without indwelling stent placement, age 12 years or older"	NP
31553	315X3	"Laryngoplasty; for laryngeal stenosis, with graft, with indwelling stent placement, younger than 12 years of age"	NP
31554	315X4	"Laryngoplasty; for laryngeal stenosis, with graft, with indwelling stent placement, age 12 years or older"	NP
31591	315X5	"Laryngoplasty, medialization, unilateral"	NP
31592	315X6	Cricotracheal resection	NP
33340	333X3	"Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation"	NP
33390	334X1	"Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; simple (ie, valvotomy, debridement, debulking, and/or simple commissural resuspension)"	NP
33391	334X2	"Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; complex (eg, leaflet extension, leaflet resection, leaflet reconstruction, or annuloplasty)"	NP
36456	364X1	"Partial exchange transfusion, blood, plasma or crystalloid necessitating the skill of a physician or other qualified health care professional, newborn"	NP
36473	36X41	"Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated"	NP
36474	364X2	"Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure)"	NP
36901	369X1	"Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report"	NP
36902	369X2	"Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report; with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty"	NP
36903	369X3	"Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report; with transcatheter placement of intravascular stent(s) peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the stenting, and all angioplasty within the peripheral dialysis segment"	NP
36904	369X4	"Percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s)"	NP
36905	369X5	"Percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s); with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty"	NP
36906	369X6	"Percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s); with transcatheter placement of an intravascular stent(s), peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the stenting, and all angioplasty within the peripheral dialysis circuit"	NP
36907	369X7	"Transluminal balloon angioplasty, central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the angioplasty (List separately in addition to code for primary procedure)"	NP
36908	369X8	"Transcatheter placement of an intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging radiological supervision and interpretation required to perform the stenting, and all angioplasty in the central dialysis segment (List separately in addition to code for primary procedure)"	NP
36909	369X9	"Dialysis circuit permanent vascular embolization or occlusion (including main circuit or any accessory veins), endovascular, including all imaging and radiological supervision and interpretation necessary to complete the intervention (List separately in addition to code for primary procedure)"	NP
37246	372X1	"Transluminal balloon angioplasty (except lower extremity artery(s) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; initial artery"	NP
37247	372X2	"Transluminal balloon angioplasty (except lower extremity artery(s) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; each additional artery (List separately in addition to code for primary procedure)"	NP
37248	372X3	"Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; initial vein"	NP
37249	372X4	"Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; each additional vein (List separately in addition to code for primary procedure)"	NP
43284	432X1	"Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed"	NP
43285	432X2	Removal of esophageal sphincter augmentation device	NP
58674	585X1	"Laparoscopy, surgical, ablation of uterine fibroid(s) including intraoperative ultrasound guidance and monitoring, radiofrequency"	NP
62320	623X5	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance"	NP
62321	623X6	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT)"	NP
62322	623X7	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance"	NP
62323	623X8	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)"	NP
62324	623X9	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance"	NP
62325	62X10	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT)"	NP
62326	62X11	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance"	NP
62327	62X12	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)"	NP
62380	630X1	"Endoscopic decompression of spinal cord, nerve root(s), including laminotomy, partial facetectomy, foraminotomy, discectomy and/or excision of herniated intervertebral disc, 1 interspace, lumbar"	NP
76706	767X1	"Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)"	NP
77065	770X1	"Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral"	NP
77066	770X2	"Diagnostic mammography, including computer-aided detection (CAD) when performed; bilateral"	NP
77067	770X3	"Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed"	NP
80305	803X1	"Drug test(s), presumptive, any number of drug classes, qualitative,  any number of devices or procedures, (eg, immunoassay) capable of being read by direct optical observation only (eg, dipsticks, cups, cards, cartridges) includes sample validation when performed, per date of service"	
80306	803X2	"Drug test(s), presumptive, any number of drug classes, qualitative,  any number of devices or procedures, (eg, immunoassay) read by instrument assisted direct optical observation (eg, dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service"	
80307	803X3	"Drug test(s), presumptive, any number of drug classes, qualitative, any number of devices or procedures by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service"	
81327	813X7	"SEPT9 (Septin9) (eg, colorectal cancer) methylation analysis"	
81539	814X1	"Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Intact PSA and human kallikrein-2 [hK2]), utilizing plasma or serum, prognostic algorithm reported as a probability score"	
81439	814X2	"Inherited cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy) genomic sequence analysis panel, must include sequencing of at least 5 genes, including DSG2, MYBPC3, MYH7, PKP2, and TTN"	
81422	814X3	"Fetal chromosomal microdeletion(s) genomic sequence analysis (eg, DiGeorge syndrome, Cri-du-chat syndrome), circulating cell-free fetal DNA in maternal blood"	
81413	814X5	"Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A"	
81414	814X6	"Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including KCNH2 and KCNQ1"	
84410	844XX	"Testosterone; bioavailable, direct measurement (eg, differential precipitation)"	
87483	878XX	"Infectious agent detection by nucleic acid (DNA or RNA); central nervous system pathogen (eg, Neisseria meningitidis, Streptococcus pneumoniae, Listeria, Haemophilus influenzae, E. coli, Streptococcus agalactiae, enterovirus, human parechovirus, herpes simplex virus type 1 and 2, human herpes virus 6, cytomegalovirus, varicella zoster virus, Cryptococcus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets"	
90674	906X2	"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"	NP
92242	922X4	"Fluorescein angiography and indocyanine-green angiography (includes multiframe imaging) performed at the same patient encounter with interpretation and report, unilateral or bilateral"	NP
93590	935X1	"Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, mitral valve"	NP
93591	935X2	"Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, aortic valve"	NP
93592	935X3	Percutaneous transcatheter closure of paravalvular leak; each additional occlusion device (List separately in addition to code for primary procedure)	NP
96160	961X0	"Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument"	NP
96161	961X1	"Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument"	NP
96377	963XX	Application of on-body injector (includes cannula insertion) for timed subcutaneous injection	NP
97161	97X61	"Physical therapy evaluation: low complexity, requiring these components:A history with no personal factors and/or comorbidities that impact the plan of care;An examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions;A clinical presentation with stable and/or uncomplicated characteristics; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, 20 minutes are spent face-to-face with the patient and/or family."	NP
97162	97X62	"Physical therapy evaluation: moderate complexity, requiring these components:A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care;An examination of body systems using standardized tests and measures in addressing a total of 3 or more elements from any of the following body structures and functions, activity limitations, and/or participation restrictions;An evolving clinical presentation with changing characteristics; andClinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, 30 minutes are spent face-to-face with the patient and/or family."	NP
97163	97X63	"Physical therapy evaluation: high complexity, requiring these components:A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care;An examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions;A clinical presentation with unstable and unpredictable characteristics; andClinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, 45 minutes are spent face-to-face with the patient and/or family."	NP
97164	97X64	"Re-evaluation of physical therapy established plan of care, requiring these components:An examination including a review of history and use of standardized tests and measures is required; andRevised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcomeTypically, 20 minutes are spent face-to-face with the patient and/or family."	NP
97165	97X65	"Occupational therapy evaluation, low complexity, requiring these components:An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem;An assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; andClinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. Patient presents with no comorbidities that affect occupational performance. Modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component.Typically, 30 minutes are spent face-to-face with the patient and/or family."	NP
97166	97X66	"Occupational therapy evaluation, moderate complexity, requiring these components:An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance;An assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; andClinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. Patient may present with comorbidities that affect occupational performance. Minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component.Typically, 45 minutes are spent face-to-face with the patient and/or family."	NP
97167	97X67	"Occupational therapy evaluation, high complexity, requiring these components:An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance;An assessment(s) that identify 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; andClinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. Patient presents with comorbidities that affect occupational performance. Significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component.Typically, 60 minutes are spent face-to-face with the patient and/or family."	NP
97168	97X68	"Re-evaluation of occupational therapy established plan of care, requiring these components:An assessment of changes in patient functional or medical status with revised plan of care;An update to the initial occupational profile to reflect changes in condition or environment that affect future interventions and/or goals; andA revised plan of care. A formal reevaluation is performed when there is a documented change in functional status or a significant change to the plan of care is required.Typically, 30 minutes are spent face-to-face with the patient and/or family."	NP
97169	97X69	"Athletic training evaluation, low complexity requiring these components:A history and physical activity profile with no comorbidities that affect physical activity;An examination of affected body area and other symptomatic or related systems addressing 1-2 elements from any of the following: body structures, physical activity, and/or participation deficiencies; andClinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
97170	97X70	"Athletic training evaluation, moderate complexity, requiring these components:A medical history and physical activity profile with 1-2 comorbidities that affect physical activity;An examination of affected body area and other symptomatic or related systems addressing a total of 3 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies; andClinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
97171	97X71	"Athletic training evaluation, high complexity, requiring these components:A medical history and physical activity profile, with 3 or more comorbidities that affect physical activity;A comprehensive examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies;Clinical presentation with unstable and unpredictable characteristics; andClinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
97172	97X72	"Reevaluation of athletic training established plan of care requiring these components:An assessment of patient’s current functional status when there is a documented change; andA revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome with an update in management options, goals, and interventions.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
99151	991X1	"Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; initial 15 minutes of intra-service time, patient younger than 5 years of age"	NP
99152	991X2	"Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; initial 15 minutes of intra-service time, patient age 5 years or older"	NP
99153	991X5	"Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; each additional 15 minutes intra-service time (List separately in addition to code for primary service)"	NP
99155	991X3	"Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intra-service time, patient younger than 5 years of age"	NP
99156	991X4	"Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intra-service time, patient age 5 years or older"	NP
99157	991X6	Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; each additional 15 minutes intra-service time (List separately in addition to code for primary service)	NP
0446T	04X1T	"Creation of subcutaneous pocket with insertion of implantable interstitial glucose sensor, including system activation and patient training"	NP
0447T	04X2T	Removal of implantable interstitial glucose sensor from subcutaneous pocket via incision	NP
0448T	04X3T	"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new implantable sensor, including system activation"	NP
0449T	04X4T	"Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial device"	NP
0450T	04X5T	"Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; each additional device (List separately in addition to code for primary procedure)"	NP
0451T	0X11T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; complete system (counterpulsation device, vascular graft, implantable vascular hemostatic seal, mechano-electrical skin interface and subcutaneous electrodes)"	NP
0452T	0X12T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; aortic counterpulsation device and vascular hemostatic seal"	NP
0453T	0X13T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; mechano-electrical skin interface"	NP
0454T	0X14T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; subcutaneous electrode"	NP
0455T	0X15T	"Removal of permanently implantable aortic counterpulsation ventricular assist system; complete system (aortic counterpulsation device, vascular hemostatic seal, mechano-electrical skin interface and electrodes)"	NP
0456T	0X16T	Removal of permanently implantable aortic counterpulsation ventricular assist system; aortic counterpulsation device and vascular hemostatic seal	NP
0457T	0X17T	Removal of permanently implantable aortic counterpulsation ventricular assist system; mechano-electrical skin interface	NP
0458T	0X18T	Removal of permanently implantable aortic counterpulsation ventricular assist system; subcutaneous electrode	NP
0459T	0X20T	"Relocation of skin pocket with replacement of implanted aortic counterpulsation ventricular assist device, mechano-electrical skin interface and electrodes"	NP
0460T	0X21T	"Repositioning of previously implanted aortic counterpulsation ventricular assist device, subcutaneous electrode"	NP
0461T	0X22T	"Repositioning of previously implanted aortic counterpulsation ventricular assist device, subcutaneous electrode; aortic counterpulsation device"	NP
0462T	0X23T	"Programming device evaluation (in person) with iterative adjustment of the implantable mechano-electrical skin interface and/or external driver to test the function of the device and select optimal permanent programmed values with analysis, including review and report, implantable aortic counterpulsation ventricular assist system, per day"	NP
0463T	0X24T	"Interrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable aortic counterpulsation ventricular assist system, per day"	NP
0464T	0X66T	"Visual evoked potential, testing for glaucoma, with interpretation and report "	NP
0465T	05X1T	Suprachoroidal injection of a pharmacologic agent (does not include supply of medication)	NP
0466T	046XT	"Insertion of chest wall respiratory sensor electrode or electrode array, including connection to pulse generator (List separately in addition to code for primary procedure)"	NP
0467T	047XT	"Revision or replacement of chest wall respiratory sensor electrode or electrode array, including connection to existing pulse generator"	NP
0468T	048XT	Removal of chest wall respiratory sensor electrode or electrode array            	NP
